Living With Breast Cancer
Being diagnosed with breast cancer can affect daily life in many ways, depending on what stage it’s at and the treatment you will have.
How people cope with the diagnosis and treatment varies from person to person. There are several forms of support available, if you need it.
Forms of support may include:
- family and friends, who can be a powerful support system
- communicating with other people in the same situation
- finding out as much as possible about your condition
- not trying to do too much or overexerting yourself
- making time for yourself
Find out more about living with breast cancer.
Can Cancer Form In Other Parts Of The Breast
Cancers can also form in other parts of the breast, but these types of cancer are less common. These can include:
- Angiosarcomas. This type of cancer begins in the cells that make up the lining of blood or lymph vessels. These cancers can start in breast tissue or breast skin. They are rare.
- Inflammatory breast cancer. This type of cancer is rare and different from other types of breast cancer. It is caused by obstructive cancer cells in the skins lymph vessels.
- Paget disease of the breast, also known as Paget disease of the nipple. This cancer affects the skin of the nipple and areola .
- Phyllodes tumors. These are rare, and most of these masses are not cancer. However, some are cancerous. These tumors begin in the breasts connective tissue, which is called the stroma.
Staging Multifocal Breast Cancer
Once breast cancer is diagnosed, additional tests are performed to stage cancer. This tells the medical team how advanced the cancer is and whether it has begun to spread to other areas of the body. Understanding the stage of cancer is an important factor when determining the appropriate treatment plan.
Read Also: Cancer Stage 3a
What Is The Most Aggressive Form Of Breast Cancer
most aggressive breast cancersbreast cancertype of breast cancerbreast cancerformcancerbreast
Also question is, what are the 4 types of breast cancer?
Types. Types of breast cancer include ductal carcinoma in situ, invasive ductal carcinoma, inflammatory breast cancer, and metastatic breast cancer. Metastatic breast cancer is also classified as Stage 4 breast cancer. The cancer has spread to other parts of the body.
how aggressive is triple negative breast cancer? In normal, healthy breast cells, the HER2 stimulates cell growth. Triple–negative breast cancer is considered to be more aggressive and have a poorer prognosis than other types of breast cancer, mainly because there are fewer targeted medicines that treat triple–negative breast cancer.
Besides, which type of breast cancer has the best prognosis?
In general, tubular, mucinous and medullary breast carcinomas have a better prognosis than the other sub-types.
What is the most aggressive form of cancer?
Top Five Most Dangerous Cancers in Men and Women
- Lung & bronchus – 87,260 male deaths in 2013.
- Prostate – 29,720 male deaths in 2013.
- Colon & rectum – 26,300 male deaths in 2013.
- Pancreas – 19,480 male deaths in 2013.
- Liver & intrahepatic bile duct – 14,890 male deaths in 2013.
Where Do These Numbers Come From
The American Cancer Society relies on information from the Surveillance, Epidemiology, and End Results Program database, maintained by the National Cancer Institute , to provide survival statistics for different types of cancer.
The SEER database tracks 5-year relative survival rates for breast cancer in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by AJCC TNM stages . Instead, it groups cancers into localized, regional, and distant stages:
- Localized: There is no sign that the cancer has spread outside of the breast.
- Regional: The cancer has spread outside the breast to nearby structures or lymph nodes.
- Distant: The cancer has spread to distant parts of the body such as the lungs, liver, or bones.
Read Also: Stage 3 B Breast Cancer
Special Invasive Breast Cancers And Carcinoma In Situ
Inflammatory breast cancer is an aggressive locally advanced breast cancer.
The main symptoms of IBC are swelling and redness in the breast. Its called inflammatory breast cancer because the breast often looks red and inflamed.
About 1-5 percent of breast cancers are IBC .
Learn more about IBC.
Paget disease of the breast is a rare carcinoma in situ in the skin of the nipple or in the skin closely surrounding the nipple. Its usually found with an underlying breast cancer.
About 1-4 percent of breast cancers also involve Paget disease of the breast .
Susan G. Komen® Support Resources
What Is A 5
A relative survival rate compares women with the same type and stage of breast cancer to women in the overall population. For example, if the 5-year relative survival rate for a specific stage of breast cancer is 90%, it means that women who have that cancer are, on average, about 90% as likely as women who dont have that cancer to live for at least 5 years after being diagnosed.
Don’t Miss: Breast Cancer Spread To Lymph Nodes Symptoms
Is Breast Cancer Curable In The 3 Stage
What does stage 3 mean? Because stage 3 breast cancer has spread outside the breast, it can be harder to treat than earlier stage breast cancer, though that depends on a few factors. With aggressive treatment, stage 3 breast cancer is curable however, the risk that the cancer will grow back after treatment is high.
Discovery Could Lead To New Treatments
The findings provide a way of distinguishing molecular differences in this diverse group of breast cancers and suggest molecular targets for each subtype that may inform drug discovery and development efforts.
In our opinion, the big breakthrough is just being able to say this isnt one disease, said Pietenpol.
Being able to distinguish distinct biological subtypes of TNBC could help guide the design of select clinical trials for subtypes of breast cancer, point toward new biomarkers for patient selection for a given therapy, and identify new targets for drug discovery, she said.
This really is the first step in translating genomic information into personalizing therapy for women with a very difficult-to-treat breast cancer.
Other Vanderbilt authors on the study were Melinda Sanders, Bapsi Chakravarthy and Yu Shyr. The research was funded by the National Cancer Institute, the American Cancer Society and the Susan G. Komen Foundation.
Explore Story Topics
Also Check: What Is The Prognosis For Stage 3 Breast Cancer
The Origins Of Tnbc Subtyping
During the last decade, several groups invested their efforts into characterizing TNBC at different molecular levels. The first attempts to stratify TNBC were based on histology, immunohistochemistry , and transcriptomic profiling . In 2013, TNBC was classified using 13 IHC markers by Elsawaf et al. This study identified four groups according to the expression patterns of cytokeratins . After subsetting, patients with luminal or basoluminal displayed a significantly worse survival than patients with basal A or basal B TNBC tumors .
Table 1 Examples of TNBC stratification methods.
How Do Tamoxifen Raloxifene Anastrozole And Exemestane Reduce The Risk Of Breast Cancer
If you are at increased risk for developing breast cancer, four medications tamoxifen , raloxifene , anastrozole , and exemestane may help reduce your risk of developing this disease. These medications act only to reduce the risk of a specific type of breast cancer called estrogen receptor-positive breast cancer. This type of breast cancer accounts for about two-thirds of all breast cancers.
Tamoxifen and raloxifene are in a class of drugs called selective estrogen receptor modulators . These drugs work by blocking the effects of estrogen in breast tissue by attaching to estrogen receptors in breast cells. Because SERMs bind to receptors, estrogen is blocked from binding. Estrogen is the fuel that makes most breast cancer cells grow. Blocking estrogen prevents estrogen from triggering the development of estrogen-receptor-positive breast cancer.
Anastrozole and exemestane are in a class of drugs called aromatase inhibitors . These drugs work by blocking the production of estrogen. Aromatase inhibitors do this by blocking the activity of an enzyme called aromatase, which is needed to make estrogen.
Recommended Reading: Estrogen Negative Progesterone Positive Breast Cancer
What Is Inflammatory Breast Cancer
Inflammatory breast cancer is an aggressive form of breast cancer that usually appears as skin inflammation and general changes in the breast, rather than as a defined lump. IBC is rather rare and only accounts for around one to five percent of diagnosed breast cancers. Educational campaigns about spotting breast cancer early usually focus on the more common forms of breast cancer, which cause lumps and changes in breast tissue that can be felt. But learning about other changes that could signal cancer can help you stay healthy.
Which Is The Most Aggressive Form Of Breast Cancer
The most aggressive breast cancers include: Triple-negative breast cancer: This type of breast cancer tests negative for the hormones estrogen and progesterone, and the protein HER2. Inflammatory breast cancer: This rare form of cancer is named because it causes breast swelling and redness.
Triple-negative breast cancer accounts for about 10-15% of all breast cancers. The term triple-negative breast cancer refers to the fact that the cancer cells dont have estrogen or progesterone receptors and also dont make too much of the protein called HER2. Sep 20, 2019
Moreover, What is the survival rate for triple negative breast cancer?
According to the American Cancer Society, the 5-year survival rate for TNBC is 77 percent.
Secondly, What form of breast cancer is the deadliest?
Metastatic Breast Cancer The most serious and dangerous breast cancers wherever they arise or whatever their type are metastatic cancers. Metastasis means that the cancer has spread from the place where it started into other tissues distant from the original tumor site.
Simply so, What is triple positive breast cancer?
A type of breast cancer in which the tumor cells have estrogen receptors, progesterone receptors, and a larger than normal number of HER2 receptors on their surface. Knowing if breast cancer is triple positive may help plan the best treatment, which may include hormone therapy and drugs that target the HER2 receptor.
Which cancer has worst survival rate?
Don’t Miss: Grade 3 Invasive Ductal Carcinoma
Expert Review And References
- American Cancer Society. Breast Cancer. 2015: .
- de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. Journal of the National Cancer Institute. Oxford University Press 2010.
- Lonning PE. Breast cancer prognostication and prediction: are we making progress?. Annals of Oncology. Oxford: Oxford University Press 2007.
- Morrow M, Burstein HJ, and Harris JR. Malignant tumors of the breast. DeVita VT Jr, Lawrence TS, & Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins 2015: 79: 1117-1156.
- Tripathy D, Eskenazi LB, Goodson, WH, et al. Breast. Ko, A. H., Dollinger, M., & Rosenbaum, E. Everyone’s Guide to Cancer Therapy: How Cancer is Diagnosed, Treated and Managed Day to Day. 5th ed. Kansas City: Andrews McMeel Publishing 2008: pp. 473-514.
The Legacy Of Bc Subtyping Using Gene Expression Patterns
Long-non-coding RNAs were considered to classify TNBC tumors by Liu et al., given their role as regulators of gene expression. They combined mRNA and lncRNA expression profiles to construct the Fudan University classification system. Similar to the findings by Lehman et al. and Burstein et al., four subtypes were identified: IM, enriched in immune cell signaling pathways LAR, enriched in hormone-related pathways MES, whose main features were low levels of cell proliferation-related genes and enriched pathways associated with epithelial-mesenchymal transition and BLIS, showing upregulation of proliferative pathways and the downregulation of genes involved in the immune response. Again, patients with BLIS TNBC showed a worse overall prognosis. The authors compared these clusters with the TNBCtype-6 classification. They found that the IM groups were nearly identical in both studies, and LAR and BLIS partially covered Lehmanns LAR and BL1 groups, respectively. The authors also designed an IHC-based approach to classify TNBC patients . Quist et al. employed a four-gene signature to cluster TNBC tumors into six subtypes. The MC6 subtype, which comprised nearly 50% of TNBC samples, was associated with a higher sensitivity to platinum-based chemotherapy. Importantly, this correlation was further validated in TNBC cell lines .
Recommended Reading: Invasive Ductal Carcinoma Grade 3 Treatment
How Much Do Anastrozole And Exemestane Lower The Risk Of Breast Cancer
Studies have shown that both anastrozole and exemestane can lower the risk of breast cancer in postmenopausal women who are at increased risk of the disease.
In one large study, taking anastrozole for five years lowered the risk of developing estrogen receptor-positive breast cancer by 53 percent. In another study, taking exemestane for three years lowered the risk of developing estrogen receptor-positive breast cancer by 65 percent.
The most common side effects seen with anastrazole and exemestane are joint pains, decreased bone density, and symptoms of menopause .
Last reviewed by a Cleveland Clinic medical professional on 12/31/2018.
What Are The Different Types Of Breast Cancer
Noninvasive breast cancer
Noninvasive cancer forms within the milk ducts or lobules in the breast. Although healthy breast tissue is not yet affected, the cancer may progress at any time and immediate treatment is crucial.
There are two main types of noninvasive breast cancer:
Invasive breast cancer
Invasive breast cancer is breast cancer that has spread outside the ducts and lobules into the surrounding tissues. Types of invasive breast cancer include:
Don’t Miss: Stage 3a Breast Cancer Survival
What Else Determines Prognosis
In addition to the stage, other factors that affect breast cancer prognosis include the type of cancer, how fast the tumor is growing, your age, your overall health, and your menopausal status.
Knowing the stage of your cancer allows your medical team to develop the most effective treatment plan for you. It also helps them to determine your prognosis and five-year survival rate. This rate is used to describe the likelihood of your treatment plan being effective. The five-year survival rates for all types of breast cancer are:
- Localized : 99%
- Regional : 86%
- Distant : 28%
Its important to note that the prognoses for unifocal and multifocal breast cancers are different. A 2017 study found that multifocal breast cancer tended to be more aggressive and have a poorer prognosis than unifocal breast cancer.
Different Types Of Aggressive Breast Cancer Identified
Vanderbilt-Ingram Cancer Center researchers have identified six subtypes of an aggressive and difficult-to-treat form of breast cancer, called triple-negative breast cancer .
In the July issue of the Journal of Clinical Investigation, Cancer Center Director Jennifer Pietenpol, and colleagues describe the molecular features of these six distinct subtypes and identify chemotherapies to which the different subtypes respond in cultured cells and animal tumor models. Knowing the specific subtype could help physicians determine which therapies would work best in patients with TNBC and also inform the discovery and development of new drugs to treat this form of breast cancer, the authors suggest.
Read Also: What Does Stage 2 Breast Cancer Mean
How Fast Does Aggressive Breast Cancer Grow
Breast cancer has to divide 30 times before it can be felt. Up to the 28th cell division, neither you nor your doctor can detect it by hand. With most breast cancers, each division takes one to two months, so by the time you can feel a cancerous lump, the cancer has been in your body for two to five years.
Additional Types Of Invasive Ductal Carcinoma:
There are four types of invasive ductal carcinoma that are less common:
- Medullary Ductal Carcinoma This type of cancer is rare and only three to five percent of breast cancers are diagnosed as medullary ductal carcinoma. The tumor usually shows up on a mammogram and it does not always feel like a lump rather it can feel like a spongy change of breast tissue.
- Mucinous Ductal Carcinoma This occurs when cancer cells within the breast produce mucous, which also contains breast cancer cells. The cells and mucous combine to form a tumor. Pure mucinous ductal carcinoma carries a better prognosis than more common types of IDCs.
- Papillary Carcinoma This is a very good prognosis breast cancer that primarily occur in women over the age of 60.
- Tubular Ductal Carcinoma This is a rare diagnosis of IDC, making up only two percent of diagnoses of breast cancer. The name comes from how the cancer looks under the microscope like hundreds of tiny tubes. Tubular breast cancer has an excellent prognosis.
Show me more…
Recommended Reading: Stage 3 Advanced Breast Cancer